You can buy or sell Inovio and other stocks, options, ETFs, and crypto commission-free!
Inovio Pharmaceuticals, Inc. Common Stock, also called Inovio, is a late-stage biotechnology company, which engages in the discovery, development, and commercialization of DNA-based immunotherapies and vaccines. Read More Its drug candidates include SynCon immunotherapies which helps break the immune system's tolerance of cancerous cells; and CELLECTRA delivery system which facilitates optimized cellular uptake of the SynCon immunotherapies. The company was founded by David B. Weiner on June 29, 1983 and is headquartered in Plymouth Meeting, PA.
Plymouth Meeting, Pennsylvania
52 Week High
52 Week Low
Expected Aug 6, After Hours